Hallucinations in Parkinson's Disease

NCT04592965 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-10-19

No results posted yet for this study

Summary

Investigation on how robotically mediated sensorimotor stimulation induces and triggers presence hallucinations in different clinical groups of parkinsonian patients, and in aged-matched controls

Conditions

  • Parkinson Disease Psychosis

Interventions

BEHAVIORAL

Clinical and neuropsychological assessments

The assessment of disease state, clinical condition, and of cognitive and neuropsychological attributes.

BEHAVIORAL

Induction of PH and associated bodily states

Assessment of subjective sensitivity to the induction of the PH and associated bodily states, for different populations of PD patients and healthy aged-matched controls

OTHER

Resting-state fMRI acquisition

Investigation of neural mechanisms at rest, that are potentially disrupted at different degrees, for the different clinical groups of PD patients, compared to the healthy aged-matched controls

OTHER

Induction of PH and associated bodily states (MRI)

Assessment of subjective sensitivity to the induction of the PH and associated bodily states, for different populations of PD patients and healthy aged-matched controls Assessment and comparison of the neural mechanisms responsible for the induction of the PH and associated bodily illusions, in different groups of PD patients and healthy aged-matched controls

Sponsors & Collaborators

  • University Hospital, Geneva

    collaborator OTHER
  • Hôpital du Valais

    collaborator OTHER
  • Insel Gruppe AG, University Hospital Bern

    collaborator OTHER
  • Centre Hospitalier Universitaire Vaudois

    collaborator OTHER
  • Hospital de Sant Pau

    collaborator OTHER
  • Olaf Blanke

    lead OTHER

Principal Investigators

  • Olaf Blanke · Ecole Polytechnique Fédérale de Lausanne

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-17
Primary Completion
2021-12-01
Completion
2021-12-01

Countries

  • Spain
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04592965 on ClinicalTrials.gov